|
HS Code |
831555 |
| Product Name | Paeoniae Radix Rubra Veterinary Grade API |
| Form | Powder |
| Appearance | Brownish-yellow powder |
| Applications | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Active Component | Paeoniflorin |
| Purity | ≥98% |
| Source | Paeonia lactiflora root |
| Intended Use | Veterinary medicine |
| Solubility | Soluble in water and ethanol |
| Shelf Life | 24 months |
| Storage Conditions | Cool, dry, and dark place |
| Packing | 25kg/drum or as required |
| Country Of Origin | China |
| Certifications | GMP, ISO9001 |
| Cas Number | 23180-57-6 |
As an accredited Paeoniae Radix Rubra Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaged in 25 kg double-layered sealed fiber drums with inner polyethylene bags, labeled for veterinary use and API identification. |
| Shipping | The shipping of Paeoniae Radix Rubra Veterinary Grade API is conducted in secure, sealed containers to ensure product integrity. It is protected from moisture, light, and contamination. Products are dispatched via reliable carriers with temperature control if required, accompanied by all necessary documentation and conforming to international transportation and safety regulations. |
| Storage | Paeoniae Radix Rubra Veterinary Grade API should be stored in a cool, dry, and well-ventilated area away from direct sunlight, heat sources, and moisture. Keep the container tightly closed and protected from contamination. Store at room temperature, ideally between 15°C and 25°C, and avoid contact with incompatible substances. Ensure proper labeling and keep out of reach of unauthorized personnel and animals. |
Applications of Paeoniae Radix Rubra Veterinary Grade API for Tablets, Injections, Capsules, Powders, Granules, Premix, and Solutions in Industrial ManufacturingPaeoniae Radix Rubra in veterinary grade active pharmaceutical ingredient (API) form finds multiple downstream applications across livestock and companion animal health manufacturing. As the direct manufacturer, we supply this ingredient to pharmaceutical producers requiring standardized herbal actives for regulated veterinary medicine formulations. The following sections detail real industrial uses, precise incorporation methods, industry-specific compliance frameworks, and the range of downstream finished product types for each sector. 1. Veterinary Tablet Manufacturing for Large Animal UseMajor pharmaceutical producers incorporate Paeoniae Radix Rubra API when formulating bulk veterinary tablets for cattle, swine, and equine indications, primarily for health support during inflammatory states and circulatory disturbance. The ingredient enters the direct blending stage with other actives and excipients following granulation and prior to compression. Proper particle size adjustment ensures uniform dispersion in solid forms and consistent oral dosing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Injectable Solution Processing for Swine and Bovine IndicationsVeterinary injectable drug manufacturers integrate Paeoniae Radix Rubra as an API standard in water-based solution preparations to address circulatory and inflammation-related illnesses in commercial animal husbandry. Following a solution-phase extraction or direct dissolution, the API is sterilized by filtration and dispensed into glass/vial packaging on dedicated fill–finish lines with in-process QC validation for sterility and concentration. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Premix and Granule Formulation for Feed Additive ProductionIndustrial feed premix and granule manufacturers in Asia and Eastern Europe utilize Paeoniae Radix Rubra API to produce standardized herbal feed additives, especially for group medication in poultry and ruminant diets. The ingredient is pre-mixed with flow agents and nutritional carriers to create uniform, stable microdispersion premixes, ensuring even distribution and bioavailability during mass blending into compound feeds. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Veterinary Capsule Manufacturing for Companion AnimalsProducers of companion animal health supplements and OTC veterinary medicinal products incorporate Paeoniae Radix Rubra API during hard capsule and powder capsule formulation. The ingredient benefits individualized dosage delivery for dogs and cats, supporting targeted supplementation for immune support and inflammation management. QC checks ensure batch-to-batch consistency in fill content and dissolution rates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Oral Solution Manufacturing for Poultry and AquacultureManufacturers serving the poultry and aquaculture segments formulate oral solution products containing Paeoniae Radix Rubra API to address flock-level health and promote recovery during stress periods. The ingredient dissolves in stabilized liquid matrices following specific pH adjustment and preservative inclusion to maintain API solubility and dosage uniformity during shelf-life. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Paeoniae Radix Rubra Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Walking into any production room in our facility, you’ll notice a common thread among the benches: every team member, from our technical managers to the quality control staff, holds a healthy respect for the roots we process. Paeoniae Radix Rubra sits at the heart of many formulas our clients rely on for animal health. We’ve grown from a modest lab to a streamlined, mid-sized manufacturer because listening to veterinarians and pharmaceutical partners shapes how we approach APIs. This product reflects years of technical rigor and onsite learning, distilled into batches you can trust.
Our Paeoniae Radix Rubra Veterinary Grade API does not settle for commodity status. We focus on consistency and clean processing, aiming for an API that supports the most demanding finished dosage forms—tablets, injections, capsules, powders, granules, premix, and solutions. Every run starts with raw roots that match an established pharmacopoeia grade. Sourcing teams visit farms directly; frequent soil and traceability checks aim to eliminate contamination risk right at the source.
Model characteristics within each batch are shaped by extraction and purification steps that discard redundant plant material, concentrating only the intended actives. We work with different particle size distributions—standard mesh cuts suit powder or granule feeds, micronized material supports tablet compression or injectable use, and all undergoes chemical profiling through HPLC fingerprinting. Veterinary clients seeking minimal excipient use value these distinctions, especially as custom blend projects make up a growing segment of demand.
Our typical Paeoniae Radix Rubra model is calibrated to contain measured percentages of paeoniflorin and related monoterpene glycosides, a feature that defines the product’s value in practical pharmacological settings. The water and ethanol extraction balance ensures minimal carrier residue, so the final API slot cleanly into animal health formulations with strict impurity targets. Shelf stability reaches up to 36 months under recommended conditions, verified by periodic in-house follow-ups, not just a single validation set.
Over more than a decade, our extraction team has field-tested over twenty process variations, always checking for a balance between yield and purity that translates into therapeutic confidence. Full traceability from harvest to packaging isn’t optional; it’s woven into each stage, so partners track every kilogram back to field data. Bioactive markers don’t just make it into the spec sheet—they appear on certificate reports, signed off in person by tech staff who know the fields firsthand.
Packing lines in our plant don’t operate in a vacuum. Each format—powder, capsule-grade fine, granulated for feed or liquid solutions—passes a separate inspection path. Our process leaders make sure common pitfalls such as caking, residual solvents, or dust contamination receive early checks. Long before tablets and injectables reach animal hospitals, multiple quality steps address these variables, logged at each point for later trace review.
Paeoniae Radix Rubra supports several classic roles in veterinary health. Its traditional use centers on inflammatory modulation and circulatory regulation in livestock, equine, and companion animal practice. Clients involved in formulating pain management solutions—especially for chronic musculoskeletal conditions—seek out our product by active marker analysis, counting on precise dosing without significant batch drift. Some opt for mixtures in feed premix lines for poultry and swine, while others press pure-grade fines into clinical trial tablets or tailor solutions for use as injectables, which demands scrupulous attention to solubility and stability.
You won’t find a one-size-fits-all suggestion from our technical service teams. Our staff interacts directly with veterinary researchers who outline dose forms or pharmacokinetic profiles unique to species range. If a client targets high-throughput tablet production, we plan joint compressibility and flow studies, not just supply a sample and walk away. Injectable product clients request additional filters—pyrogenicity, particle size microfiltration—that we adjust for in our post-extraction finishing lines.
API-to-excipient interactions matter in the finished dosage form, especially where animal welfare hinges on accurate administration and predictable release. We test our API both in small-scale bench runs and larger scaleups, comparing dissolution rates in tablet cores, sedimentation profiles in premix blends, and chemical compatibility in injectable solutions. This habit of full-chain practical testing means partner firms encounter fewer surprises during product registration or scaleup validation.
A reputation in API manufacturing rests not just on price, but a grounded understanding of animal health priorities. Raw material procurement, early cleanroom pilot runs, finished formulation—the glue holding this together is process transparency. You see this day-to-day in how we conduct external audits: visitors walk our extraction floors, inspect batch records, and monitor operator training directly. Questions aren’t pushed off—they spur process tweaks that strengthen lot-to-lot reliability.
Our company invested heavily in analytical stations that keep up with evolving pharmacopoeia and local veterinary safety standards. This means HPLC, UV, and microbial screening results aren’t just recorded; we use trends in that data to redesign extraction steps, drying curves, or particle sizing. Living through regulatory inspections shapes our view of product stewardship, as fines for deviations go beyond paperwork—they can compromise animal outcomes in real-world cases, a risk our team refuses to take.
Over the past five years, several partners have faced disruptions due to import control or supply chain volatility. During these transitions, our team pivoted quickly—not by cutting corners, but by expanding single-origin root partnerships and streamlining our internal release cycle. Protecting product integrity across capsules, tablets, and premix shipments became a defining feature of our offering. We learned that clients trust manufacturers who don’t gamble with quality for a faster ship date.
Working at the manufacturing end teaches honesty about strengths and tradeoffs. Paeoniae Radix Rubra stands out from many botanical APIs for its reproducible pharmacological impact at practical dose levels. Some alternative veterinary extracts, especially newer botanicals, exhibit wide variability in pure marker content, or pose extraction stability problems that complicate scaleup. Our familiarity with this root—down to its harvest chemistry—keeps batch consistency higher, so animal health strategies relying on predictable dose administration gain a measurable edge.
We’ve benchmarked our API against several traditional alternatives and synthetic actives. Botanical APIs like Scutellaria or Glycyrrhiza often bring useful flavonoids yet struggle with solubility in finished dose forms. Synthetic agents can offer intensity but often lack the broader modulation profile that Paeoniae Radix Rubra brings, particularly around inflammation and capillary function. Our process eliminates common impurities noted in lower-tier raw root suppliers, such as sulfur dioxide residues or aflatoxin risk—frequent in batches passing through long trading chains or silo storage.
Veterinary clients shifting from overseas supply chains mention issues with fingerprint drift and moisture variation, which can derail regulatory approvals. By setting physical control up front, from drying parameters to micronization mesh selection, we sidestep the “unexpected out-of-spec” syndrome that regularly plagues less direct supply models. Experience teaches the highest-risk points show up post-milling and during storage, so our logistics arm built a just-in-time movement system for direct shipments—key for global distribution across time zones.
Years handling real-world client dilemmas have shaped our approach to problem-solving. Requested custom particle size for pelletizing? Our team runs a bench trial and ships you a test batch the same week. Facing last-minute regulatory paperwork or batch release questions? Your assigned project lead walks through every data point rather than hiding behind generic responses. Chronic shortages after natural disasters spurred us to build secondary raw material reserves, which allowed us to keep major veterinary clients supplied without cutting quality steps.
Veterinary APIs require more than chemical purity on a spec sheet—they demand responsiveness across changing demand, regulations, and even animal welfare campaigns. We listen closely when a client flags solubility issues in a canine liquid suspension or reports unexpected sediment in cattle supplements. Each feedback round feeds into our next technical review and production batch, tightening our process and broadening our internal knowledge base.
Training isn’t outsourced or handled by template; our technical staff rotate through R&D, QA, and client support. This mix translates into practical advice when a partner faces hurdles with tableting yield losses or stability shifts in granule lines. Examples include realigning dryer set points during unexpected humidity surges, or updating filtration in injection intermediates when new veterinary pharmacopoeial guidelines appear. Every challenge we’ve faced—whether regulatory, technical, or supply-related—informs the next round of best practices, ensuring our Paeoniae Radix Rubra API lines up with field realities, not just lab targets.
Problems rarely emerge under ideal conditions. Our operational planning makes a difference once markets face pressure—traceability must hold even when harvests contract or logistics stall. Knowing each batch’s journey from field to package grants confidence in crisis recovery and simplifies batch recall procedures. Our data system links purchase order all the way to original planting block, so tracebacks run within hours, not weeks. This detail makes a direct impact on both client regulatory audits and internal self-assessments.
Avoiding middlemen and long trade chains trims risk substantially. Direct contracts with root growers mean we set—and enforce—residue standards, fertilization schedules, and handling protocols. Every field visit and sample run happens on-site, with actual operator dialogue rather than relying on report chains that obscure facts. Over the last three years, global shifts in freight and customs scrutiny have made redundant documentation a real bottleneck. Our in-house logistics and regulatory teams adapted quickly, bundling clear batch certificates and compliance files ready for any customs desk, easing entry through multiple frontiers.
There are no shortcuts on the path to trustworthy animal products, especially with APIs facing tight regulatory scrutiny. Environmental controls in our production lines don’t lag behind industry trends—they result from annual reviews, regular GMP inspections, and external audits. Each piece of feedback—positive or negative—feeds the loop for line upgrades or SOP rewrites. Before release, batch samples pass through independent microbiological and heavy metal screening, with records accessible in real-time to partner QA teams.
Strict pesticide and heavy metal standards remain non-negotiable. We voluntarily expanded our contaminant screening panels before observed residue warnings in North America and the EU picked up. This foresight has helped clients navigate sudden regulatory demands without shifting suppliers mid-project or holding back product launches. We’ve maintained a lower deviation rate across release lots by reinforcing staff training and creating accountability checkpoints at every layer—blending trust in people with reliable control protocols.
Our compliance attitude reflects the reality that animal health outcomes start with ingredient integrity. Paeoniae Radix Rubra’s full chain of custody ensures that every client, from multinational conglomerates to smaller specialty labs, receives exactly the profile they expect each time. We stand ready to provide supporting technical files, continuous dialogue, and hands-on support for clients seeking veterinary applications that meet both global and local requirements.
The landscape in veterinary APIs keeps shifting. Veterinary professionals see new diseases, resistance profiles, and animal health targets. Clients ask for APIs ready for tomorrow’s dosage forms, not just today’s. Each year, we reinvest profits into refining our extraction hardware, expanding our QC toolset, and upgrading process control software, so our partners find their future needs met ahead of schedule.
Veterinary research partnerships bring us new challenges: tighter impurity thresholds, calls for improved API stability in tropical climates, or companion animal dose flexibility. We maintain a technical dialogue with each R&D collaborator, hosting on-site visits and building joint pilot batches, fostering real trust and technical understanding faster than any written bulleted checklist. This open model lets us spot fresh needs or hurdles—ensuring the product continually improves based on actual field use and the shifting ground of animal health science.
Manufacturers who view API as just another commodity miss the real opportunity to contribute meaningfully to veterinary medicine. For our team, every inquiry is a potential improvement point. Real-time feedback from animal clinics or field trials becomes practical data that shapes our operations. We don’t chase transient trends or offer empty promises about what the product can deliver. We stay grounded in what has worked, while reaching for improvements that keep animal health moving forward.
As the field of veterinary pharmaceuticals continues to evolve, so do the standards for trusted ingredients. We keep the product moving toward future expectations—higher purity, consistent dosing, smart packaging options, and always, a transparent and responsive supply chain. By staying in direct conversation with the people who rely on our Paeoniae Radix Rubra Veterinary Grade API, we make sure animal health, client experience, and regulatory compliance always move in step.